COVID-19 treatment in the older people: a brief clinical review

  • Giovanni Cenderello | g.cenderello@asl1.liguria.it Infectious Diseases Department, ASL-1 Imperiese, Sanremo, Italy.
  • Simone Dini Geriatrics Unit, Department Geriatric Care, Orthogeriatrics and Rehabilitation, EO Ospedali Galliera, Genova, Italy.
  • Serena Ziliani Oncology Department ASL1 Imperiese, Sanremo, Italy.
  • Crocefissa Fiorella Casuccio SC Medicina Interna, EO Ospedali Galliera, Genova, Italy.
  • Francesca Mori Ubaldini Infectious Diseases Department, ASL-1 Imperiese, Sanremo, Italy.

Abstract

This paper summarizes the latest data about the treatment options available for coronavirus disease 2019 (COVID-19), paying special attention to the older patients. This review explored both trials that have included older patients and some clinically relevant drug-drug interactions. The data have been updated to 31st October, 2020. In particular, details have been reported about the use of antivirals, heparin, steroid and hyperimmune plasma.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-12-28
Info
Issue
Section
Good clinical practices
Keywords:
COVID-19 treatment, older people, aging, drug-drug interactions.
Statistics
  • Abstract views: 154

  • PDF: 124
  • HTML: 0
How to Cite
Cenderello, G., Dini, S., Ziliani, S., Casuccio, C. F., & Mori Ubaldini, F. (2020). COVID-19 treatment in the older people: a brief clinical review. Geriatric Care, 6(4). https://doi.org/10.4081/gc.2020.9330